Evidence map›Paper›PMID 29120834›Full record

ArticleCancer epidemiology2017

Cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in four US-Affiliated Pacific Islands between 2007 and 2015.

Virginia Senkomago, Janet Royalty, Jacqueline W Miller, Lee E Buenconsejo-Lum, Vicki B Benard, Mona Saraiya

Abstract read
In one paragraph

Article in Cancer epidemiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Virginia SenkomagoDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: vsenkomago@cdc.gov.
Janet RoyaltyDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Jacqueline W MillerDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Lee E Buenconsejo-LumDepartment of Family Medicine and Community Health, Pacific Regional Cancer Programs, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, United States.
Vicki B BenardDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Mona SaraiyaDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Funding

USAPIN PACIFIC REGIONAL CENTRAL CANCER REGISTRYU58DP000835 · DP · UNIVERSITY OF HAWAII AT MANOA · PI BUENCONSEJO-LUM, LEE ELLEN · 2007 to 2011
$2.8M
USAPI PACIFIC REGIONAL CENTRAL CANCER REGISTRY (PRCCR)U58DP003906 · DP · UNIVERSITY OF HAWAII AT MANOA · PI BUENCONSEJO-LUM, LEE ELLEN · 2012 to 2014
$1.6M
NCCDPHP CDC HHS U58 DP000835NCCDPHP CDC HHS U58 DP003906
6 · The paper itself

Abstract

backgroundCervical cancer incidence in the US-Affiliated Pacific Islands (USAPIs) is double that of the US mainland. American Samoa, Commonwealth of Northern Mariana Islands (CNMI), Guam and the Republic of Palau receive funding from the Centers for Disease Control (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) to implement cervical cancer screening to low-income, uninsured or under insured women. The USAPI grantees report data on screening and follow-up activities to the CDC. MATERIALS AND

methodsWe examined cervical cancer screening and follow-up data from the NBCCEDP programs in the four USAPIs from 2007 to 2015. We summarized screening done by Papanicolaou (Pap) and oncogenic human papillomavirus (HPV) tests, follow-up and diagnostic tests provided, and histology results observed.

resultsA total of 22,249 Pap tests were conducted in 14,206 women in the four USAPIs programs from 2007-2015. The overall percentages of abnormal Pap results (low-grade squamous intraepithelial lesions or worse) was 2.4% for first program screens and 1.8% for subsequent program screens. Histology results showed a high proportion of cervical intraepithelial neoplasia grade 2 or worse (57%) among women with precancers and cancers. Roughly one-third (32%) of Pap test results warranting follow-up had no data recorded on diagnostic tests or follow-up done.

conclusionThis is the first report of cervical cancer screening and outcomes of women served in the USAPI through the NBCCEDP with similar results for abnormal Pap tests, but higher proportion of precancers and cancers, when compared to national NBCCEDP data. The USAPI face significant challenges in implementing cervical cancer screening, particularly in providing and recording data on diagnostic tests and follow-up. The screening programs in the USAPI should further examine specific barriers to follow-up of women with abnormal Pap results and possible solutions to address them.

Indexed as

AdultEarly Detection of CancerFemaleHumansMass ScreeningMedically UninsuredMiddle AgedPacific IslandsPapanicolaou TestPovertyUterine Cervical NeoplasmsVaginal SmearsCervical cancerNBCCEDPScreeningUS-Affiliated Pacific IslandsUS territories

Identifiers

PMID29120834
PMCPMC5739878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.